IL142778A0 - Therapeutic product and its use - Google Patents

Therapeutic product and its use

Info

Publication number
IL142778A0
IL142778A0 IL14277899A IL14277899A IL142778A0 IL 142778 A0 IL142778 A0 IL 142778A0 IL 14277899 A IL14277899 A IL 14277899A IL 14277899 A IL14277899 A IL 14277899A IL 142778 A0 IL142778 A0 IL 142778A0
Authority
IL
Israel
Prior art keywords
therapeutic product
therapeutic
product
Prior art date
Application number
IL14277899A
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9826536.6A external-priority patent/GB9826536D0/en
Priority claimed from GBGB9826535.8A external-priority patent/GB9826535D0/en
Priority claimed from GBGB9826537.4A external-priority patent/GB9826537D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of IL142778A0 publication Critical patent/IL142778A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
IL14277899A 1998-12-02 1999-12-02 Therapeutic product and its use IL142778A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9826536.6A GB9826536D0 (en) 1998-12-02 1998-12-02 Therapeutic product and its use
GBGB9826535.8A GB9826535D0 (en) 1998-12-02 1998-12-02 Therapeutic product and its use
GBGB9826537.4A GB9826537D0 (en) 1998-12-02 1998-12-02 Therapeutic product and its use
PCT/GB1999/004021 WO2000032558A1 (en) 1998-12-02 1999-12-02 Therapeutic product and its use

Publications (1)

Publication Number Publication Date
IL142778A0 true IL142778A0 (en) 2002-03-10

Family

ID=27269570

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14277899A IL142778A0 (en) 1998-12-02 1999-12-02 Therapeutic product and its use

Country Status (12)

Country Link
EP (1) EP1135361A1 (en)
JP (1) JP2002531431A (en)
KR (1) KR20010080364A (en)
CN (1) CN1329590A (en)
AU (1) AU1400100A (en)
BR (1) BR9915873A (en)
CA (1) CA2350635A1 (en)
HU (1) HUP0104420A2 (en)
IL (1) IL142778A0 (en)
NO (1) NO20012738D0 (en)
PL (1) PL347542A1 (en)
WO (1) WO2000032558A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1313460A2 (en) * 1999-11-09 2003-05-28 Darwin Discovery Limited Therapeutic use and formulation of (-)-tramadol
JP2004513091A (en) * 2000-10-03 2004-04-30 ペンウェスト　ファーマシューティカルズ　カンパニー Delivery systems for multiple pharmaceutically active ingredients at different rates
DE10108122A1 (en) * 2001-02-21 2002-10-02 Gruenenthal Gmbh Medicines based on tramadol
AU2002364517A1 (en) 2001-11-30 2003-06-17 Sepracor Inc. Tramadol analogs and uses thereof
CA2616204C (en) 2005-09-09 2015-12-01 Labopharm Inc. Sustained drug release composition
CA2677691C (en) 2007-02-12 2012-07-31 David Bar-Or Reducing side effects of tramadol
MX2009012685A (en) * 2007-05-31 2009-12-14 Sepracor Inc Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors.
JOP20190251A1 (en) * 2017-05-31 2019-10-21 Metys Pharmaceuticals AG Synergistic compositions comprising (r)-dimiracetam (1) and (s)-dimiracetam (2) in a non-racemic ratio
SG11202005016SA (en) 2017-12-05 2020-06-29 Sunovion Pharmaceuticals Inc Nonracemic mixtures and uses thereof
JP2021505595A (en) 2017-12-05 2021-02-18 サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． Crystal form and its manufacturing method
AU2019394706A1 (en) * 2018-12-04 2021-05-20 Metys Pharmaceuticals AG Synergistic compositions comprising R-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2H)-ones and S-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2H)-ones in a non-racemic ratio
CN114401717A (en) 2019-06-04 2022-04-26 赛诺维信制药公司 Modified release formulations and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204116A (en) * 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy
PL335619A1 (en) * 1997-03-11 2000-05-08 Darwin Discovery Ltd Dosage forms including separate parts containing r and s enantiomers
DE19807535A1 (en) * 1998-02-21 1999-08-26 Asta Medica Ag Drug combination for treating migraine, migraine-type headaches or pain accompanied by nausea, vomiting or delayed gastric emptying

Also Published As

Publication number Publication date
CA2350635A1 (en) 2000-06-08
CN1329590A (en) 2002-01-02
AU1400100A (en) 2000-06-19
WO2000032558A1 (en) 2000-06-08
HUP0104420A2 (en) 2002-08-28
NO20012738L (en) 2001-06-01
NO20012738D0 (en) 2001-06-01
PL347542A1 (en) 2002-04-08
KR20010080364A (en) 2001-08-22
BR9915873A (en) 2001-08-21
JP2002531431A (en) 2002-09-24
EP1135361A1 (en) 2001-09-26

Similar Documents

Publication Publication Date Title
GB9415125D0 (en) Surgical product and its use
PL335555A1 (en) Novel compounds - substituted benzamides and therapeutic agent
PL347542A1 (en) Therapeutic product and its use
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
GB9615435D0 (en) Spray-dried product and its therapeutic use
GB9812662D0 (en) Therapeutic use
GB9810920D0 (en) Therapeutic use
GB9816897D0 (en) Therapeutic use
GB9616504D0 (en) Therapeutic product and its use
GB9826539D0 (en) Therapeutic product and its use
GB9826537D0 (en) Therapeutic product and its use
GB9826536D0 (en) Therapeutic product and its use
GB9826535D0 (en) Therapeutic product and its use
GB9821179D0 (en) Therapeutic use
GB9811624D0 (en) Therapeutic use
GB9929581D0 (en) Comjpositions and their use
GB9616508D0 (en) Therapeutic product and its use
GB9616505D0 (en) Therapeutic product and its use
GB9616507D0 (en) Therapeutic product and its use
GB9616506D0 (en) Therapeutic product and its use
GB9616510D0 (en) Therapeutic product and its use
GB9616550D0 (en) Therapeutic product and its use
GB9616823D0 (en) Therapeutic product and its use
GB9616503D0 (en) Therapeutic product and its use